FDA to scrutinize unproven cancer drugs after gap
Published: April 26, 2021

WASHINGTON (AP) —Each year the U.S. approves dozens of new uses for cancer drugs based on early signs that they can shrink or slow the spread of tumors. But...
Subscribe Today!
Advertisement